• Please log in or register to access this feature.

Letter to the Editor

You have full text access to this OnlineOpen article

Methylation status in patients with early stage colon cancer: A new prognostic marker?

  1. Susanna Zanutto1,2,
  2. Sara Pizzamiglio3,
  3. Andrea Lampis4,
  4. Tiziana Camerini5,
  5. Maria G. Di Mauro5,
  6. Marco A. Pierotti5,
  7. Paolo Verderio3,
  8. Manuela Gariboldi1,2,†,*

Article first published online: 25 APR 2011

DOI: 10.1002/ijc.26011

Issue

International Journal of Cancer

International Journal of Cancer

Volume 130, Issue 2, pages 488–489, 15 January 2012

Additional Information

How to Cite

Zanutto, S., Pizzamiglio, S., Lampis, A., Camerini, T., Di Mauro, M. G., Pierotti, M. A., Verderio, P. and Gariboldi, M. (2012), Methylation status in patients with early stage colon cancer: A new prognostic marker?. Int. J. Cancer, 130: 488–489. doi: 10.1002/ijc.26011

Author Information

  1. 1

    Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori Milano, Milano, Italy

  2. 2

    Unit of Molecular Genetics of Cancer, IFOM Foundation, Milano, Italy

  3. 3

    Unit of Medical Statistics, Biometry and Bioinformatics, Fondazione IRCCS Istituto Nazionale dei Tumori Milano, Milano, Italy

  4. 4

    Unit of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori Milano, Milano, Italy

  5. 5

    Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori Milano, Milano, Italy

  1. †

    Tel.: +39+2-23902042, Fax: +39+2-23903141

*DOSSM, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, via G. Venezian, 1 20133 Milano, Italy

  1. †

    Tel.: +39+2-23902042, Fax: +39+2-23903141

Publication History

  1. Issue published online: 23 NOV 2011
  2. Article first published online: 25 APR 2011
  3. Accepted manuscript online: 23 FEB 2011 11:11AM EST
  4. Manuscript Accepted: 2 FEB 2011
  5. Manuscript Received: 3 JAN 2011

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (92K)

References

  • 1
    Andre T, Sargent D, Tabernero J, O'Connell M, Buyse M, Sobrero A, Misset JL, Boni C, de Gramont A. Current issues in adjuvant treatment of stage II colon cancer. Ann Surg Oncol 2006; 13: 887–98.
  • 2
    Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, Somerfield MR, Hayes DF, Bast RC Jr. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006; 24: 5313–27.
  • 3
    Andersen CL, Lamy P, Thorsen K, Kjeldsen E, Wikman F, Villesen P, Oster B, Laurberg S, Orntoft TF. Frequent genomic loss at chr16p13.2 is associated with poor prognosis in colorectal cancer. Int J Cancer, 2010 Dec 10. [Epub ahead of print].
  • 4
    Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer 2004; 4: 988–93.
  • 5
    Goel A, Nagasaka T, Arnold CN, Inoue T, Hamilton C, Niedzwiecki D, Compton C, Mayer RJ, Goldberg R, Bertagnolli MM, Boland CR. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology 2007; 132: 127–38.
  • 6
    Ward RL, Cheong K, Ku SL, Ku SL, Meagher A, O'Connor T, Hawkins NJ. Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability. J Clin Oncol 2003; 21: 3729–36.
  • 7
    Kim JH, Shin SH, Kwon HJ, Cho NY, Kang GH. Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers. Virchows Arch 2009; 455: 485–94.
  • 8
    Lee S, Cho NY, Yoo EJ, Kim JH, Kang GH. CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels. Arch Pathol Lab Med 2008; 132: 1657–65.
  • 9
    Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Meyerhardt JA, Loda M, Giovannucci EL, Fuchs CS. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut 2009; 58: 90–6.
  • 10
    Ahn JB, Chung WB, Maeda O, Shin SJ, Kim HS, Chung HC, Kim NK, Issa JP. DNA methylation predicts recurrence from resected stage III proximal colon cancer. Cancer, 2010 Nov 18. [Epub ahead of print].
View Full Article (HTML) Get PDF (92K)